Sinovac Biotech, Ltd
SVA
SVA was delisted on the 22nd of February, 2019.
36 hedge funds and large institutions have $66.9M invested in Sinovac Biotech, Ltd in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 4 closing their positions.
8% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 13
3% less funds holding
Funds holding: 37 → 36 (-1)
5% less capital invested
Capital invested by funds: $70.8M → $66.9M (-$3.86M)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$791K |
| 2 |
Renaissance Technologies
New York
|
+$464K |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$423K |
| 4 |
Two Sigma Investments
New York
|
+$202K |
| 5 |
VAM
Verity Asset Management
Durham,
North Carolina
|
+$175K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$2.6M |
| 2 |
First Manhattan
New York
|
-$2M |
| 3 |
Citigroup
New York
|
-$1.03M |
| 4 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$72.7K |
| 5 |
SIM
Spark Investment Management
New York
|
-$61K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Simplex Trading
Chicago,
Illinois
| $48K | +$43.8K | +7,454 | +1,065% |
|
27
JP Morgan Chase
New York
| $27K | +$23.4K | +3,984 | +763% |
|
|
AG
28
Advisor Group
Phoenix,
Arizona
| $23K | – | – | – |
|
|
CG
29
Cutler Group
San Francisco,
California
| $16K | -$588 | -100 | -3% |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| $14K | -$753 | -128 | -5% |
|
31
Wells Fargo
San Francisco,
California
| $7K | – | – | – |
|
|
IA
32
IFP Advisors
Tampa,
Florida
| $6K | – | – | – |
|
33
UBS Group
Zurich,
Switzerland
| $6K | +$5.26K | +894 | +843% |
|
34
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $3K | – | – | – |
|
35
Creative Planning
Overland Park,
Kansas
| $3K | +$2.94K | +500 | New |
|
|
LTFS
36
Ladenburg Thalmann Financial Services
Miami,
Florida
| $2K | -$512 | -87 | -22% |
|
|
37
First Manhattan
New York
| – | -$2M | -336,747 | Closed |
|
|
SIM
38
Spark Investment Management
New York
| – | -$61K | -10,300 | Closed |
|
|
KAM
39
Kassirer Asset Management
Toronto,
Ontario, Canada
| – | -$59K | -10,000 | Closed |
|
40
Walleye Trading
New York
| – | -$23K | -3,800 | Closed |
|
SVA Hedge Fund Activity: Q3 2016 in Review
36 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech, Ltd (SVA) for Q3 2016, worth a combined $66.9M — down 5.5% from $70.8M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of SVA and 3 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 12 added.
The largest buyer was Wellington Management Group, adding an estimated $791K. The largest seller was Pine River Capital Management, cutting an estimated $2.6M.
- 36 institutional investors held Sinovac Biotech, Ltd (SVA) as of Q3 2016, down from 37 in Q2 2016.
- Funds reported $66.9M of Sinovac Biotech, Ltd stock for Q3 2016, down 5.5% quarter-over-quarter.
- 3 funds opened new Sinovac Biotech, Ltd positions in Q3 2016 and 4 closed out, a net change of -1 holder.
- The largest Sinovac Biotech, Ltd buyer in Q3 2016 was Wellington Management Group, an estimated $791K added.
- The largest Sinovac Biotech, Ltd seller in Q3 2016 was Pine River Capital Management, an estimated $2.6M sold.
Based on aggregated 13F filings for Q3 2016.